Future research directions in chronic obstructive pulmonary disease
TL Croxton, GG Weinmann, RM Senior… - American journal of …, 2002 - atsjournals.org
Between 3 and 7 million Americans are currently diagnosed with chronic obstructive
pulmonary disease (COPD), and the true prevalence is probably greater than 16 million (1) …
pulmonary disease (COPD), and the true prevalence is probably greater than 16 million (1) …
Why new biology must be uncovered to advance therapeutic strategies for chronic obstructive pulmonary disease
JMK Nguyen, DN Robinson… - American Journal of …, 2021 - journals.physiology.org
Chronic obstructive pulmonary disease (COPD) is characterized by the destruction of
alveolar tissue (in emphysema) and airway remodeling (leading to chronic bronchitis), which …
alveolar tissue (in emphysema) and airway remodeling (leading to chronic bronchitis), which …
Emerging drugs for chronic obstructive pulmonary disease
MG Matera, L Calzetta, A Segreti… - Expert opinion on …, 2012 - Taylor & Francis
Introduction: Chronic obstructive pulmonary disease (COPD) is a major public health
problem with increasing morbidity and mortality. It is characterized by airflow obstruction that …
problem with increasing morbidity and mortality. It is characterized by airflow obstruction that …
Mechanisms, pathophysiology and currently proposed treatments of chronic obstructive pulmonary disease
SO Rodrigues, CMC Cunha, GMV Soares, PL Silva… - Pharmaceuticals, 2021 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is one of the leading global causes of
morbidity and mortality. A hallmark of COPD is progressive airflow obstruction primarily …
morbidity and mortality. A hallmark of COPD is progressive airflow obstruction primarily …
Update in chronic obstructive pulmonary disease in 2010
MLK Han - American journal of respiratory and critical care …, 2011 - atsjournals.org
The year 2010 marked several milestones for chronic obstructive pulmonary disease
(COPD). Unfortunately, COPD moved from fourth leading cause of death in the United States …
(COPD). Unfortunately, COPD moved from fourth leading cause of death in the United States …
Update on the pathogenesis of chronic obstructive pulmonary disease
Update on the Pathogenesis of Chronic Obstructive Pulmonary Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Update on clinical aspects of chronic obstructive pulmonary disease
BR Celli, JA Wedzicha - New England Journal of Medicine, 2019 - Mass Medical Soc
Update on Clinical Aspects of Chronic Obstructive Pulmonary Disease | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Systemic effects of chronic obstructive pulmonary disease
AGN Agustí - Chronic Obstructive Pulmonary Disease …, 2000 - Wiley Online Library
Traditionally, chronic obstructive pulmonary disease (COPD) has been understood as a
disease of the lungs, characterized by irreversible airflow limitation due to chronic bronchitis …
disease of the lungs, characterized by irreversible airflow limitation due to chronic bronchitis …
Burden and pathogenesis of chronic obstructive pulmonary disease
The burden of chronic obstructive pulmonary disease (COPD) is rising, incurring a major
health care burden worldwide. There is no specific therapy other than smoking cessation …
health care burden worldwide. There is no specific therapy other than smoking cessation …
Emerging drugs for the treatment of chronic obstructive pulmonary disease
By 2020 chronic obstructive pulmonary disease (COPD) will be the third leading cause of
mortality and fifth leading cause of morbidity. Research over the past two decades has shed …
mortality and fifth leading cause of morbidity. Research over the past two decades has shed …